188 related articles for article (PubMed ID: 8714677)
21. Pathogenesis of two axonopathies does not require axonal neurofilaments.
Eyer J; Cleveland DW; Wong PC; Peterson AC
Nature; 1998 Feb; 391(6667):584-7. PubMed ID: 9468135
[TBL] [Abstract][Full Text] [Related]
22. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
23. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?
Julien JP; Beaulieu JM
J Neurol Sci; 2000 Nov; 180(1-2):7-14. PubMed ID: 11090858
[TBL] [Abstract][Full Text] [Related]
24. Neurofilaments in health and disease.
Gotow T
Med Electron Microsc; 2000; 33(4):173-99. PubMed ID: 11810476
[TBL] [Abstract][Full Text] [Related]
25. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS).
Tomkins J; Usher P; Slade JY; Ince PG; Curtis A; Bushby K; Shaw PJ
Neuroreport; 1998 Dec; 9(17):3967-70. PubMed ID: 9875737
[TBL] [Abstract][Full Text] [Related]
26. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.
Millecamps S; Robertson J; Lariviere R; Mallet J; Julien JP
J Neurochem; 2006 Aug; 98(3):926-38. PubMed ID: 16787413
[TBL] [Abstract][Full Text] [Related]
27. Neuron-glia interactions underlie ALS-like axonal cytoskeletal pathology.
King AE; Dickson TC; Blizzard CA; Woodhouse A; Foster SS; Chung RS; Vickers JC
Neurobiol Aging; 2011 Mar; 32(3):459-69. PubMed ID: 19427060
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.
Manser C; Stevenson A; Banner S; Davies J; Tudor EL; Ono Y; Leigh PN; McLoughlin DM; Shaw CE; Miller CCJ
FEBS Lett; 2008 Jun; 582(15):2303-2308. PubMed ID: 18519042
[TBL] [Abstract][Full Text] [Related]
29. Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit.
Beaulieu JM; Jacomy H; Julien JP
J Neurosci; 2000 Jul; 20(14):5321-8. PubMed ID: 10884316
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
31. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS.
Lobsiger CS; Garcia ML; Ward CM; Cleveland DW
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10351-6. PubMed ID: 16002469
[TBL] [Abstract][Full Text] [Related]
32. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.
Nguyen MD; Larivière RC; Julien JP
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12306-11. PubMed ID: 11050249
[TBL] [Abstract][Full Text] [Related]
33. Neurofilaments, radial growth of axons, and mechanisms of motor neuron disease.
Williamson TL; Marszalek JR; Vechio JD; Bruijn LI; Lee MK; Xu Z; Brown RH; Cleveland DW
Cold Spring Harb Symp Quant Biol; 1996; 61():709-23. PubMed ID: 9246497
[No Abstract] [Full Text] [Related]
34. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.
Boylan K; Yang C; Crook J; Overstreet K; Heckman M; Wang Y; Borchelt D; Shaw G
J Neurochem; 2009 Dec; 111(5):1182-91. PubMed ID: 19765193
[TBL] [Abstract][Full Text] [Related]
35. A simple test to monitor the motor dysfunction in a transgenic mouse model of amyotrophic lateral sclerosis.
Collard JF; Julien JP
J Psychiatry Neurosci; 1995 Jan; 20(1):80-2. PubMed ID: 7865504
[TBL] [Abstract][Full Text] [Related]
36. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease.
Lee MK; Marszalek JR; Cleveland DW
Neuron; 1994 Oct; 13(4):975-88. PubMed ID: 7946341
[TBL] [Abstract][Full Text] [Related]
37. Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis.
al-Chalabi A; Powell JF; Leigh PN
Muscle Nerve; 1995 May; 18(5):540-5. PubMed ID: 7739643
[TBL] [Abstract][Full Text] [Related]
38. Dysregulation of human NEFM and NEFH mRNA stability by ALS-linked miRNAs.
Campos-Melo D; Hawley ZCE; Strong MJ
Mol Brain; 2018 Jul; 11(1):43. PubMed ID: 30029677
[TBL] [Abstract][Full Text] [Related]
39. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
40. Alterations in neural intermediate filament organization: functional implications and the induction of pathological changes related to motor neuron disease.
Straube-West K; Loomis PA; Opal P; Goldman RD
J Cell Sci; 1996 Sep; 109 ( Pt 9)():2319-29. PubMed ID: 8886982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
